Zarkan, Ashraf Matuszewska, Marta Trigg, Stephen B Zhang, Meng Belgami, Daaniyah Croft, Cameron Liu, Junyan El-Ouisi, Sawssen Greenhalgh, Jack Duboff, James S
...
Persisters are a sub-population of genetically sensitive bacteria that survive antibiotic treatment by entering a dormant state. The emergence of persisters from dormancy after antibiotic withdrawal leads to recurrent infection. Indole is an aromatic molecule with diverse signalling roles, including a role in persister formation. Here we demonstrat...
Mahamat-Saleh, Y Aune, D Schlesinger, S
Sun exposure is a major environmental risk factor for skin cancers and is also an important source of vitamin D. However, while experimental evidence suggests that vitamin D may have a protective effect on skin cancer risk, epidemiologic studies investigating the influence of 25-hydroxyvitamin D (25(OH)D) level and/or vitamin D intake on skin cance...
Al-Sharabi, Mohammed Markl, Daniel Mudley, Theona Bawuah, Prince Karttunen, Anssi-Pekka Ridgway, Cathy Gane, Patrick Ketolainen, Jarkko Peiponen, Kai-Erik Rades, Thomas
...
Fast disintegrating tablets have commonly been used for fast oral drug delivery to patients with swallowing difficulties. The different characteristics of the pore structure of such formulations influence the liquid transport through the tablet and hence affect the disintegration time and the release of the drug in the body. In this work, terahertz...
Prokoph, Nina Probst, Nicola A Lee, Liam C Monahan, Jack M Matthews, Jamie D Liang, Huan-Chang Bahnsen, Klaas Montes-Mojarro, Ivonne A Karaca-Atabay, Elif Sharma, Geeta G
...
Anaplastic large cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by a hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, provide alternatives to standard chemotherapy with reduced toxicity and side effects. Children with lymphomas driven by nucleophosmin 1 (NPM1)-ALK fusion proteins ach...
Frank, Diane E. Schnell, Frederick J. Akana, Cody El-Husayni, Saleh H. Desjardins, Cody A. Morgan, Jennifer Charleston, Jay S. Sardone, Valentina Domingos, Joana Dickson, George
...
peer reviewed / OBJECTIVE: To report safety, pharmacokinetics, exon 53 skipping, and dystrophin expression in golodirsen-treated patients with Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping. METHODS: Part 1 was a randomized, double-blind, placebo-controlled, 12-week dose titration of once-weekly golodirsen; part 2 is an ongoing, ope...
Janowitz, Tobias Gablenz, Eva Pattinson, David Wang, Timothy C Conigliaro, Joseph Tracey, Kevin Tuveson, David
OBJECTIVE: Treatment options for non-hospitalised patients with coronavirus disease 2019 (COVID-19) to reduce morbidity, mortality and spread of the disease are an urgent global need. The over-the-counter histamine-2 receptor antagonist famotidine is a putative therapy for COVID-19. We quantitively assessed longitudinal changes in patient reported ...
Sarker, Debashis Plummer, Ruth Meyer, Tim Sodergren, Mikael H Basu, Bristi Chee, Cheng Ean Huang, Kai-Wen Palmer, Daniel H Ma, Yuk Ting Evans, TR Jeff
...
PURPOSE: Transcription factor C/EBP-α (CCAAT/enhancer-binding protein alpha) acts as a master regulator of hepatic and myeloid functions and multiple oncogenic processes. MTL-CEBPA is a first-in-class small activating RNA oligonucleotide drug that upregulates C/EBP-α. PATIENTS AND METHODS: We conducted a phase I, open-label, dose-escalation trial o...
Labeur, Tim A Hofsink, Quincy Takkenberg, R Bart van Delden, Otto M Mathôt, Ron AA Schinner, Regina Malfertheiner, Peter Amthauer, Holger Schütte, Kerstin Basu, Bristi
...
Background: Sorafenib for advanced hepatocellular carcinoma (HCC) is dose adjusted by toxicity. Preliminary studies have suggested an association between plasma concentrations of sorafenib and its main metabolite (M2) and clinical outcomes. This study aimed to validate these findings and establish target values for sorafenib trough concentrations.M...
Bakker, Charlotte Prins, Samantha Liptrot, Jan Hart, Ellen P Klaassen, Erica S Brown, Giles A Brown, Alastair Congreve, Miles Weir, Malcolm Marshall, Fiona H
...
AIMS: HTL0009936 is a selective M1 muscarinic receptor agonist in development for cognitive dysfunction in Alzheimer's disease. Safety, tolerability and pharmacokinetics and exploratory pharmacodynamic effects of HTL0009936 administered by continuous IV infusion at steady state were investigated in elderly subjects with below average cognitive func...
Hajiev, Saur Allara, Elias Motedayеn Aval, Leila Arizumi, Tadaaki Bettinger, Dominik Pirisi, Mario Rimassa, Lorenza Pressiani, Tiziana Personeni, Nicola Giordano, Laura
...
BACKGROUND: There is no consensus on the effect of sorafenib dosing on efficacy and toxicity in elderly patients with hepatocellular carcinoma (HCC). Older patients are often empirically started on low-dose therapy with the aim to avoid toxicities while maximising clinical efficacy. We aimed to verify whether age impacts on overall survival (OS) an...